Solid Tumors And Hamatological Malignancies clinical trials

Explore recruiting solid tumors and hamatological malignancies clinical trials.

Also recruiting in Europe

Solid Tumors And Hamatological Malignancies trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Open-Label, Multicenter, Long-term Extension Study of Treatment With Tislelizumab, Pamiparib, and Other Investigational Agents in Patients With Advanced Malignancies

Italy, Poland, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Solid Tumors And Hamatological Malignancies trials by city

Solid Tumors And Hamatological Malignancies in Toronto Solid Tumors And Hamatological Malignancies in Vancouver Solid Tumors And Hamatological Malignancies in Montreal Solid Tumors And Hamatological Malignancies in Calgary Solid Tumors And Hamatological Malignancies in Edmonton Solid Tumors And Hamatological Malignancies in Ottawa Solid Tumors And Hamatological Malignancies in Winnipeg Solid Tumors And Hamatological Malignancies in Quebec City Solid Tumors And Hamatological Malignancies in Hamilton Solid Tumors And Hamatological Malignancies in Kitchener Solid Tumors And Hamatological Malignancies in London Solid Tumors And Hamatological Malignancies in Halifax Solid Tumors And Hamatological Malignancies in New York Solid Tumors And Hamatological Malignancies in Los Angeles Solid Tumors And Hamatological Malignancies in Chicago Solid Tumors And Hamatological Malignancies in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease